Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan™ Technology Platform

Ksenya Cohen Katsenelson, PhD, Group Leader, San Diego R&D

Dr Ksenya Cohen Katsenelson is the group leader and scientific lead of San Diego R&D at Eurofins Discovery, responsible for developing new portfolios of biochemical assays, including in the targeted protein degradation space. Ksenya holds a PhD in Biomedical Sciences from the Technion – Israel Institute of Technology, Israel. She has extensive experience of over 10 years in signal transduction pathways, biochemical and molecular biology assays and she has published multiple papers in scientific journals.